DOLISHALE Drug Patent Profile
When do Dolishale patents expire, and when can generic versions of Dolishale launch?
Dolishale is a drug marketed by Novast Labs and is included in one NDA.
The generic ingredient in DOLISHALE is ethinyl estradiol; levonorgestrel. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOLISHALE?
- What are the global sales for DOLISHALE?
- What is Average Wholesale Price for DOLISHALE?
Summary for DOLISHALE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Drug Prices: | Drug price information for DOLISHALE |
| DailyMed Link: | DOLISHALE at DailyMed |
Pharmacology for DOLISHALE
| Drug Class | Estrogen Progestin Progestin-containing Intrauterine System |
| Mechanism of Action | Estrogen Receptor Agonists |
| Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for DOLISHALE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | DOLISHALE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 091692-001 | Oct 22, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
